NCT05468970 Study on Clinical Features, Treatment Mode and Survival of Bone and Soft Tissue Tumors
| NCT ID | NCT05468970 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Henan Cancer Hospital |
| Condition | Bone and Soft Tissue Tumors |
| Study Type | OBSERVATIONAL |
| Enrollment | 6,000 participants |
| Start Date | 2022-08-03 |
| Primary Completion | 2032-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 6,000 participants in total. It began in 2022-08-03 with a primary completion date of 2032-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
It is planned to prospectively collect, collate and report real-world clinical data of BSTS patients treated in our hospital in the next ten years to evaluate the changes in clinical characteristics, treatment patterns and survival information of these patients, in order to provide reference for clinical treatment and research of this type of tumor.
Eligibility Criteria
Inclusion Criteria: All ages, male and female. The pathological diagnosis of BSTS in our hospital was a subtype. Has received at least one hospitalization in this hospital. The target lesions could be evaluated according to the efficacy evaluation criteria of solid tumor (RECIST; Version 1.1) Measure diameter changes. Exclusion Criteria: No definite pathology.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05468970 clinical trial?
This trial is open to participants of all sexes, aged 6 Years or older, up to 99 Years, studying Bone and Soft Tissue Tumors. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05468970 currently recruiting?
Yes, NCT05468970 is actively recruiting participants. Contact the research team at wjqwtj@126.com for enrollment information.
Where is the NCT05468970 trial being conducted?
This trial is being conducted at Zhengzhou, China.
Who is sponsoring the NCT05468970 clinical trial?
NCT05468970 is sponsored by Henan Cancer Hospital. The trial plans to enroll 6,000 participants.